PubMed:10432288
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 1522-1525 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
| T2 | 1691-1694 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-5 | protein | denotes | Bcl-2 |
| T2 | 68-109 | protein | denotes | nuclear factor of activated T lymphocytes |
| T3 | 111-115 | protein | denotes | NFAT |
| T4 | 125-128 | protein | denotes | Fas |
| T5 | 151-156 | protein | denotes | Bcl-2 |
| T6 | 289-294 | protein | denotes | Bcl-2 |
| T7 | 382-394 | protein | denotes | Bcl-2 family |
| T8 | 403-406 | protein | denotes | Bax |
| T9 | 411-414 | protein | denotes | Bad |
| T10 | 520-531 | protein | denotes | microtubule |
| T11 | 557-560 | protein | denotes | Fas |
| T12 | 560-571 | protein | denotes | /Fas ligand |
| T13 | 573-577 | protein | denotes | FasL |
| T14 | 609-613 | protein | denotes | FasL |
| T15 | 672-677 | protein | denotes | Bcl-2 |
| T16 | 768-772 | protein | denotes | FasL |
| T17 | 851-856 | protein | denotes | Bcl-2 |
| T18 | 895-899 | protein | denotes | NFAT |
| T19 | 901-942 | protein | denotes | nuclear factor of activated T lymphocytes |
| T20 | 946-966 | protein | denotes | transcription factor |
| T21 | 980-991 | protein | denotes | microtubule |
| T22 | 1099-1103 | protein | denotes | NFAT |
| T23 | 1136-1140 | protein | denotes | NFAT |
| T24 | 1168-1172 | protein | denotes | FasL |
| T25 | 1260-1271 | protein | denotes | microtubule |
| T26 | 1334-1338 | protein | denotes | FasL |
| T27 | 1353-1358 | protein | denotes | Bcl-2 |
| T28 | 1408-1419 | protein | denotes | calcineurin |
| T29 | 1441-1445 | protein | denotes | NFAT |
| T30 | 1484-1488 | protein | denotes | FasL |
| T31 | 1516-1521 | protein | denotes | Bcl-2 |
| T32 | 1586-1591 | protein | denotes | Bcl-2 |
| T33 | 1608-1613 | protein | denotes | Bcl-2 |
| T34 | 1626-1637 | protein | denotes | calcineurin |
| T35 | 1643-1647 | protein | denotes | NFAT |
| T36 | 1660-1664 | protein | denotes | FasL |
| T37 | 1707-1712 | protein | denotes | Bcl-2 |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-6 | NP | denotes | Bcl-2- |
| C44 | 46-55 | NP | denotes | apoptosis |
| C2 | 68-117 | NP | denotes | nuclear factor of activated T lymphocytes (NFAT)- |
| C3 | 151-156 | NP | denotes | Bcl-2 |
| C6 | 187-207 | NP | denotes | a variety of stimuli |
| C7 | 219-237 | NP | denotes | chemotherapy drugs |
| C8 | 242-257 | NP | denotes | glucocorticoids |
| C9 | 289-294 | NP | denotes | Bcl-2 |
| C11 | 302-305 | NP | denotes | its |
| C10 | 302-327 | NP | denotes | its antiapoptotic effects |
| C12 | 442-467 | NP | denotes | the antiapoptotic effects |
| C15 | 480-490 | NP | denotes | Paclitaxel |
| C13 | 495-506 | NP | denotes | other drugs |
| C14 | 507-511 | NP | denotes | that |
| C33 | 557-579 | NP | denotes | Fas/Fas ligand (FasL)- |
| C18 | 623-634 | NP | denotes | paclitaxel- |
| C16 | 623-651 | NP | denotes | paclitaxel-induced apoptosis |
| C41 | 768-772 | NP | denotes | FasL |
| C19 | 784-795 | NP | denotes | paclitaxel- |
| C17 | 784-812 | NP | denotes | paclitaxel-induced apoptosis |
| C20 | 851-856 | NP | denotes | Bcl-2 |
| C27 | 895-899 | NP | denotes | NFAT |
| C28 | 866-899 | NP | denotes | the nuclear translocation of NFAT |
| C22 | 1028-1039 | NP | denotes | calcineurin |
| C24 | 1041-1072 | NP | denotes | a calcium-dependent phosphatase |
| C25 | 1073-1077 | NP | denotes | that |
| C26 | 1099-1103 | NP | denotes | NFAT |
| C23 | 1041-1126 | NP | denotes | a calcium-dependent phosphatase that must dephosphorylate NFAT to move to the nucleus |
| C29 | 1136-1162 | NP | denotes | NFAT nuclear translocation |
| C34 | 1164-1177 | NP | denotes | the FasL gene |
| C30 | 1220-1230 | NP | denotes | paclitaxel |
| C31 | 1235-1246 | NP | denotes | other drugs |
| C32 | 1247-1251 | NP | denotes | that |
| C35 | 1334-1338 | NP | denotes | FasL |
| C36 | 1441-1467 | NP | denotes | NFAT nuclear translocation |
| C37 | 1516-1521 | NP | denotes | Bcl-2 |
| C38 | 1586-1591 | NP | denotes | Bcl-2 |
| C42 | 1567-1591 | NP | denotes | phosphorylation of Bcl-2 |
| C45 | 1681-1690 | NP | denotes | apoptosis |
| C43 | 1707-1728 | NP | denotes | Bcl-2 phosphorylation |
| R1 | C3 | C1 | coref-ident | Bcl-2,Bcl-2- |
| R2 | C7 | C6 | coref-part-whole | chemotherapy drugs,a variety of stimuli |
| R3 | C8 | C6 | coref-part-whole | glucocorticoids,a variety of stimuli |
| R4 | C9 | C3 | coref-ident | Bcl-2,Bcl-2 |
| R5 | C10 | C9 | coref-pron | its antiapoptotic effects,Bcl-2 |
| R6 | C12 | C11 | coref-ident | the antiapoptotic effects,its |
| R7 | C14 | C13 | coref-relat | that,other drugs |
| R8 | C16 | C15 | coref-ident | paclitaxel-induced apoptosis,Paclitaxel |
| R9 | C41 | C33 | coref-ident | FasL,Fas/Fas ligand (FasL)- |
| R10 | C19 | C18 | coref-ident | paclitaxel-,paclitaxel- |
| R11 | C17 | C16 | coref-ident | paclitaxel-induced apoptosis,paclitaxel-induced apoptosis |
| R12 | C20 | C9 | coref-ident | Bcl-2,Bcl-2 |
| R13 | C27 | C2 | coref-ident | NFAT,nuclear factor of activated T lymphocytes (NFAT)- |
| R14 | C25 | C24 | coref-relat | that,a calcium-dependent phosphatase |
| R15 | C26 | C27 | coref-ident | NFAT,NFAT |
| R16 | C23 | C22 | coref-appos | a calcium-dependent phosphatase that must dephosphorylate NFAT to move to the nucleus,calcineurin |
| R17 | C29 | C28 | coref-ident | NFAT nuclear translocation,the nuclear translocation of NFAT |
| R18 | C34 | C41 | coref-ident | the FasL gene,FasL |
| R19 | C30 | C17 | coref-ident | paclitaxel,paclitaxel-induced apoptosis |
| R20 | C32 | C31 | coref-relat | that,other drugs |
| R21 | C35 | C34 | coref-ident | FasL,the FasL gene |
| R22 | C36 | C29 | coref-ident | NFAT nuclear translocation,NFAT nuclear translocation |
| R23 | C37 | C20 | coref-ident | Bcl-2,Bcl-2 |
| R24 | C38 | C37 | coref-ident | Bcl-2,Bcl-2 |
| R25 | C45 | C44 | coref-ident | apoptosis,apoptosis |
| R26 | C43 | C42 | coref-ident | Bcl-2 phosphorylation,phosphorylation of Bcl-2 |
semrep-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| E1-ti-1 | 0-5 | cui:C1153488 | denotes | Bcl-2 |
| E2-ti-1 | 6-14 | cui:C0086597 | denotes | mediated |
| E3-ti-1 | 15-30 | cui:C0013203 | denotes | drug resistance |
| E4-ti-1 | 46-55 | cui:C0162638 | denotes | apoptosis |
| E5-ti-1 | 68-75 | cui:C0521447 | denotes | nuclear |
| E6-ti-1 | 59-82 | cui:C0053851 | denotes | blocking nuclear factor |
| E7-ti-1 | 86-109 | cui:C1515879 | denotes | activated T lymphocytes |
| E8-ti-1 | 117-124 | cui:C0205263 | denotes | induced |
| E9-ti-1 | 125-135 | cui:C0253023 | denotes | Fas ligand |
| E10-ti-1 | 136-149 | cui:C0040649 | denotes | transcription |
| T1 | 32-42 | DISRUPTS | denotes | inhibition |
| T2 | 83-85 | PART_OF | denotes | of |
| E1-ab-1 | 151-156 | cui:C1153488 | denotes | Bcl-2 |
| E2-ab-1 | 166-175 | cui:C0162638 | denotes | apoptosis |
| E3-ab-1 | 200-207 | cui:C0234402 | denotes | stimuli |
| E4-ab-1 | 232-237 | cui:C0013227 | denotes | drugs |
| E5-ab-1 | 242-257 | cui:C0017710 | denotes | glucocorticoids |
| E1-ab-2 | 289-294 | cui:C1153488 | denotes | Bcl-2 |
| E2-ab-2 | 320-327 | cui:C1280500 | denotes | effects |
| E3-ab-2 | 367-374 | cui:C0680022 | denotes | members |
| E4-ab-2 | 382-387 | cui:C1153488 | denotes | Bcl-2 |
| E5-ab-2 | 388-394 | cui:C0015576 | denotes | family |
| E6-ab-2 | 403-406 | cui:C0812198 | denotes | Bax |
| E7-ab-2 | 411-414 | cui:C0205169 | denotes | Bad |
| T3 | 320-327 | INTERACTS_WITH | denotes | effects |
| E1-ab-3 | 429-438 | cui:C0441712 | denotes | mechanism |
| E2-ab-3 | 460-467 | cui:C1280500 | denotes | effects |
| E1-ab-4 | 480-490 | cui:C0144576 | denotes | Paclitaxel |
| E2-ab-4 | 501-506 | cui:C0013227 | denotes | drugs |
| E3-ab-4 | 520-531 | cui:C0026046 | denotes | microtubule |
| E4-ab-4 | 546-551 | cui:C0007634 | denotes | cells |
| E5-ab-4 | 557-560 | entrez:355 | denotes | Fas |
| E6-ab-4 | 561-571 | cui:C0253023 | denotes | Fas ligand |
| T4 | 480-506 | ISA | denotes | Paclitaxel and other drugs |
| T5 | 480-506 | ISA | denotes | Paclitaxel and other drugs |
| T6 | 541-545 | DISRUPTS | denotes | kill |
| T7 | 541-545 | DISRUPTS | denotes | kill |
| T8 | 480-506 | DISRUPTS | denotes | Paclitaxel and other drugs |
| T9 | 480-506 | DISRUPTS | denotes | Paclitaxel and other drugs |
| E1-ab-5 | 597-605 | cui:C0003241 | denotes | antibody |
| E2-ab-5 | 609-613 | cui:C0253023 | denotes | FasL |
| E3-ab-5 | 623-633 | cui:C0144576 | denotes | paclitaxel |
| E4-ab-5 | 634-641 | cui:C0205263 | denotes | induced |
| E5-ab-5 | 642-651 | cui:C0162638 | denotes | apoptosis |
| T10 | 614-622 | DISRUPTS | denotes | inhibits |
| E1-ab-6 | 672-677 | cui:C1153488 | denotes | Bcl-2 |
| E2-ab-6 | 706-716 | cui:C0687732 | denotes | prevention |
| E3-ab-6 | 720-732 | cui:C0013216 | denotes | chemotherapy |
| E4-ab-6 | 734-744 | cui:C0144576 | denotes | paclitaxel |
| E5-ab-6 | 746-753 | cui:C0205263 | denotes | induced |
| E6-ab-6 | 754-764 | cui:C0185117 | denotes | expression |
| E7-ab-6 | 768-772 | cui:C0253023 | denotes | FasL |
| E8-ab-6 | 784-794 | cui:C0144576 | denotes | paclitaxel |
| E9-ab-6 | 795-802 | cui:C0205263 | denotes | induced |
| E10-ab-6 | 803-812 | cui:C0162638 | denotes | apoptosis |
| T11 | 720-744 | ISA | denotes | chemotherapy (paclitaxel |
| T12 | 777-783 | AFFECTS | denotes | blocks |
| E1-ab-7 | 818-827 | cui:C0441712 | denotes | mechanism |
| E2-ab-7 | 836-842 | cui:C1280500 | denotes | effect |
| E3-ab-7 | 851-856 | cui:C1153488 | denotes | Bcl-2 |
| E4-ab-7 | 870-891 | cui:C1518440 | denotes | nuclear translocation |
| E5-ab-7 | 901-908 | cui:C0521447 | denotes | nuclear |
| E6-ab-7 | 909-915 | cui:C1521761 | denotes | factor |
| E7-ab-7 | 919-942 | cui:C1515879 | denotes | activated T lymphocytes |
| E8-ab-7 | 946-966 | cui:C0040648 | denotes | transcription factor |
| E9-ab-7 | 980-991 | cui:C0026046 | denotes | microtubule |
| E10-ab-7 | 1015-1027 | cui:C0869026 | denotes | sequestering |
| E11-ab-7 | 1028-1039 | cui:C0054450 | denotes | calcineurin |
| E12-ab-7 | 1043-1051 | cui:C0006675 | denotes | calcium- |
| E13-ab-7 | 1061-1072 | cui:C0031678 | denotes | phosphatase |
| E1-ab-8 | 1141-1162 | cui:C1518440 | denotes | nuclear translocation |
| E2-ab-8 | 1168-1172 | cui:C0253023 | denotes | FasL |
| E3-ab-8 | 1173-1177 | cui:C0017337 | denotes | gene |
| E4-ab-8 | 1181-1184 | cui:C1518422 | denotes | not |
| E1-ab-9 | 1220-1230 | cui:C0144576 | denotes | paclitaxel |
| E2-ab-9 | 1241-1246 | cui:C0013227 | denotes | drugs |
| E3-ab-9 | 1260-1271 | cui:C0026046 | denotes | microtubule |
| E4-ab-9 | 1272-1280 | cui:C0542341 | denotes | function |
| E5-ab-9 | 1281-1285 | cui:C1550555 | denotes | kill |
| E6-ab-9 | 1286-1291 | cui:C0007634 | denotes | cells |
| E7-ab-9 | 1304-1308 | cui:C0449719 | denotes | part |
| E8-ab-9 | 1321-1330 | cui:C0857127 | denotes | induction |
| E9-ab-9 | 1334-1338 | cui:C0253023 | denotes | FasL |
| T13 | 1220-1246 | ISA | denotes | paclitaxel and other drugs |
| T14 | 1220-1246 | ISA | denotes | paclitaxel and other drugs |
| T15 | 1321-1330 | STIMULATES | denotes | induction |
| T16 | 1321-1330 | STIMULATES | denotes | induction |
| T17 | 1220-1246 | STIMULATES | denotes | paclitaxel and other drugs |
| T18 | 1220-1246 | STIMULATES | denotes | paclitaxel and other drugs |
| E1-ab-10 | 1353-1358 | cui:C1153488 | denotes | Bcl-2 |
| E2-ab-10 | 1371-1383 | cui:C0458082 | denotes | drug-induced |
| E3-ab-10 | 1384-1393 | cui:C0162638 | denotes | apoptosis |
| E4-ab-10 | 1397-1407 | cui:C0311403 | denotes | inhibiting |
| E5-ab-10 | 1408-1419 | cui:C0054450 | denotes | calcineurin |
| E6-ab-10 | 1446-1467 | cui:C1518440 | denotes | nuclear translocation |
| E7-ab-10 | 1473-1483 | cui:C1292733 | denotes | preventing |
| E8-ab-10 | 1484-1488 | cui:C0253023 | denotes | FasL |
| E9-ab-10 | 1489-1499 | cui:C0185117 | denotes | expression |
| T19 | 1420-1430 | STIMULATES | denotes | activation |
| E1-ab-11 | 1505-1512 | cui:C1280500 | denotes | effects |
| E2-ab-11 | 1516-1521 | cui:C1153488 | denotes | Bcl-2 |
| E3-ab-11 | 1567-1582 | cui:C0031715 | denotes | phosphorylation |
| E4-ab-11 | 1586-1591 | cui:C1153488 | denotes | Bcl-2 |
| E1-ab-12 | 1608-1613 | cui:C1153488 | denotes | Bcl-2 |
| E2-ab-12 | 1626-1637 | cui:C0054450 | denotes | calcineurin |
| E3-ab-12 | 1660-1664 | cui:C0253023 | denotes | FasL |
| E4-ab-12 | 1665-1675 | cui:C0185117 | denotes | expression |
| E5-ab-12 | 1681-1690 | cui:C0162638 | denotes | apoptosis |
| E6-ab-12 | 1707-1712 | cui:C1153488 | denotes | Bcl-2 |
| E7-ab-12 | 1713-1728 | cui:C0031715 | denotes | phosphorylation |
| R1 | E6-ti-1 | T1 | subjectOf | blocking nuclear factor,inhibition |
| R2 | E4-ti-1 | T1 | objectOf | apoptosis,inhibition |
| R3 | E6-ti-1 | T2 | subjectOf | blocking nuclear factor,of |
| R4 | E7-ti-1 | T2 | objectOf | activated T lymphocytes,of |
| R5 | E3-ab-2 | T3 | subjectOf | members,effects |
| R6 | E5-ab-2 | T3 | objectOf | family,effects |
| R7 | E1-ab-4 | T4 | subjectOf | Paclitaxel,Paclitaxel and other drugs |
| R8 | E2-ab-4 | T4 | objectOf | drugs,Paclitaxel and other drugs |
| R9 | E2-ab-4 | T5 | subjectOf | drugs,Paclitaxel and other drugs |
| R10 | E1-ab-4 | T5 | objectOf | Paclitaxel,Paclitaxel and other drugs |
| R11 | E2-ab-4 | T6 | subjectOf | drugs,kill |
| R12 | E4-ab-4 | T6 | objectOf | cells,kill |
| R13 | E1-ab-4 | T7 | subjectOf | Paclitaxel,kill |
| R14 | E4-ab-4 | T7 | objectOf | cells,kill |
| R15 | E1-ab-4 | T8 | subjectOf | Paclitaxel,Paclitaxel and other drugs |
| R16 | E4-ab-4 | T8 | objectOf | cells,Paclitaxel and other drugs |
| R17 | E2-ab-4 | T9 | subjectOf | drugs,Paclitaxel and other drugs |
| R18 | E4-ab-4 | T9 | objectOf | cells,Paclitaxel and other drugs |
| R19 | E2-ab-5 | T10 | subjectOf | FasL,inhibits |
| R20 | E5-ab-5 | T10 | objectOf | apoptosis,inhibits |
| R21 | E4-ab-6 | T11 | subjectOf | paclitaxel,chemotherapy (paclitaxel |
| R22 | E3-ab-6 | T11 | objectOf | chemotherapy,chemotherapy (paclitaxel |
| R23 | E7-ab-6 | T12 | subjectOf | FasL,blocks |
| R24 | E10-ab-6 | T12 | objectOf | apoptosis,blocks |
| R25 | E1-ab-9 | T13 | subjectOf | paclitaxel,paclitaxel and other drugs |
| R26 | E2-ab-9 | T13 | objectOf | drugs,paclitaxel and other drugs |
| R27 | E2-ab-9 | T14 | subjectOf | drugs,paclitaxel and other drugs |
| R28 | E1-ab-9 | T14 | objectOf | paclitaxel,paclitaxel and other drugs |
| R29 | E2-ab-9 | T15 | subjectOf | drugs,induction |
| R30 | E9-ab-9 | T15 | objectOf | FasL,induction |
| R31 | E1-ab-9 | T16 | subjectOf | paclitaxel,induction |
| R32 | E9-ab-9 | T16 | objectOf | FasL,induction |
| R33 | E1-ab-9 | T17 | subjectOf | paclitaxel,paclitaxel and other drugs |
| R34 | E9-ab-9 | T17 | objectOf | FasL,paclitaxel and other drugs |
| R35 | E2-ab-9 | T18 | subjectOf | drugs,paclitaxel and other drugs |
| R36 | E9-ab-9 | T18 | objectOf | FasL,paclitaxel and other drugs |
| R37 | E8-ab-10 | T19 | subjectOf | FasL,activation |
| R38 | E5-ab-10 | T19 | objectOf | calcineurin,activation |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-150 | Sentence | denotes | Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. |
| S2 | 151-258 | Sentence | denotes | Bcl-2 inhibits apoptosis induced by a variety of stimuli, including chemotherapy drugs and glucocorticoids. |
| S3 | 259-415 | Sentence | denotes | It is generally accepted that Bcl-2 exerts its antiapoptotic effects mainly by dimerizing with proapoptotic members of the Bcl-2 family such as Bax and Bad. |
| S4 | 416-479 | Sentence | denotes | However, the mechanism of the antiapoptotic effects is unclear. |
| S5 | 480-652 | Sentence | denotes | Paclitaxel and other drugs that disturb microtubule dynamics kill cells in a Fas/Fas ligand (FasL)-dependent manner; antibody to FasL inhibits paclitaxel-induced apoptosis. |
| S6 | 653-813 | Sentence | denotes | We have found that Bcl-2 overexpression leads to the prevention of chemotherapy (paclitaxel)-induced expression of FasL and blocks paclitaxel-induced apoptosis. |
| S7 | 814-1127 | Sentence | denotes | The mechanism of this effect is that Bcl-2 prevents the nuclear translocation of NFAT (nuclear factor of activated T lymphocytes, a transcription factor activated by microtubule damage) by binding and sequestering calcineurin, a calcium-dependent phosphatase that must dephosphorylate NFAT to move to the nucleus. |
| S8 | 1128-1197 | Sentence | denotes | Without NFAT nuclear translocation, the FasL gene is not transcribed. |
| S9 | 1198-1339 | Sentence | denotes | Thus, it appears that paclitaxel and other drugs that disturb microtubule function kill cells at least in part through the induction of FasL. |
| S10 | 1340-1500 | Sentence | denotes | Furthermore, Bcl-2 antagonizes drug-induced apoptosis by inhibiting calcineurin activation, blocking NFAT nuclear translocation, and preventing FasL expression. |
| S11 | 1501-1592 | Sentence | denotes | The effects of Bcl-2 can be overcome, at least partially, through phosphorylation of Bcl-2. |
| S12 | 1593-1729 | Sentence | denotes | Phosphorylated Bcl-2 cannot bind calcineurin, and NFAT activation, FasL expression, and apoptosis can occur after Bcl-2 phosphorylation. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-5 | protein_molecule | denotes | Bcl-2 |
| T2 | 46-55 | other_name | denotes | apoptosis |
| T3 | 68-109 | protein_molecule | denotes | nuclear factor of activated T lymphocytes |
| T4 | 111-115 | protein_molecule | denotes | NFAT |
| T5 | 125-128 | protein_molecule | denotes | Fas |
| T6 | 151-156 | protein_molecule | denotes | Bcl-2 |
| T7 | 166-175 | other_name | denotes | apoptosis |
| T8 | 219-237 | other_organic_compound | denotes | chemotherapy drugs |
| T9 | 242-257 | lipid | denotes | glucocorticoids |
| T10 | 289-294 | protein_molecule | denotes | Bcl-2 |
| T11 | 306-327 | other_name | denotes | antiapoptotic effects |
| T12 | 382-387 | protein_molecule | denotes | Bcl-2 |
| T13 | 403-406 | protein_molecule | denotes | Bax |
| T14 | 411-414 | protein_molecule | denotes | Bad |
| T15 | 446-467 | other_name | denotes | antiapoptotic effects |
| T16 | 480-490 | other_organic_compound | denotes | Paclitaxel |
| T17 | 520-531 | protein_complex | denotes | microtubule |
| T18 | 557-560 | protein_molecule | denotes | Fas |
| T19 | 560-571 | protein_molecule | denotes | /Fas ligand |
| T20 | 573-577 | protein_molecule | denotes | FasL |
| T21 | 609-613 | protein_molecule | denotes | FasL |
| T22 | 642-651 | other_name | denotes | apoptosis |
| T23 | 672-677 | protein_molecule | denotes | Bcl-2 |
| T24 | 720-734 | other_name | denotes | chemotherapy ( |
| T25 | 734-744 | other_organic_compound | denotes | paclitaxel |
| T26 | 768-772 | protein_molecule | denotes | FasL |
| T27 | 784-794 | other_organic_compound | denotes | paclitaxel |
| T28 | 803-812 | other_name | denotes | apoptosis |
| T29 | 851-856 | protein_molecule | denotes | Bcl-2 |
| T30 | 895-899 | protein_molecule | denotes | NFAT |
| T31 | 901-942 | protein_family_or_group | denotes | nuclear factor of activated T lymphocytes |
| T32 | 946-966 | protein_family_or_group | denotes | transcription factor |
| T33 | 980-991 | protein_complex | denotes | microtubule |
| T34 | 1099-1103 | protein_molecule | denotes | NFAT |
| T35 | 1119-1126 | cell_component | denotes | nucleus |
| T36 | 1136-1140 | protein_molecule | denotes | NFAT |
| T37 | 1168-1172 | protein_molecule | denotes | FasL |
| T38 | 1220-1230 | other_organic_compound | denotes | paclitaxel |
| T39 | 1260-1271 | protein_complex | denotes | microtubule |
| T40 | 1334-1338 | protein_molecule | denotes | FasL |
| T41 | 1353-1358 | protein_molecule | denotes | Bcl-2 |
| T42 | 1384-1393 | other_name | denotes | apoptosis |
| T43 | 1408-1419 | protein_molecule | denotes | calcineurin |
| T44 | 1441-1445 | protein_molecule | denotes | NFAT |
| T45 | 1484-1488 | protein_molecule | denotes | FasL |
| T46 | 1516-1521 | protein_molecule | denotes | Bcl-2 |
| T47 | 1586-1591 | protein_molecule | denotes | Bcl-2 |
| T48 | 1608-1613 | protein_molecule | denotes | Bcl-2 |
| T49 | 1626-1637 | protein_molecule | denotes | calcineurin |
| T50 | 1643-1647 | protein_molecule | denotes | NFAT |
| T51 | 1660-1664 | protein_molecule | denotes | FasL |
| T52 | 1681-1690 | other_name | denotes | apoptosis |
| T53 | 1707-1712 | protein_molecule | denotes | Bcl-2 |
metamap-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1354-1359 | C0376515 | denotes | cl-2 |
| T2 | 852-857 | C0376515 | denotes | cl-2 |
| T3 | 673-678 | C0376515 | denotes | cl-2 |
| T4 | 152-157 | C0376515 | denotes | cl-2 |
| T5 | 1-6 | C0376515 | denotes | cl-2- |
| T6 | 930-943 | C0039194 | denotes | lymphocytes, |
| T7 | 97-110 | C0039194 | denotes | lymphocytes |
| T8 | 137-150 | C0040649 | denotes | ranscription. |
| T9 | 16-31 | C0013203 | denotes | rug resistance: |
| T10 | 33-56 | C1512772 | denotes | nhibition of apoptosis |
| T11 | 1221-1231 | C0144576 | denotes | aclitaxel |
| T12 | 624-634 | C0144576 | denotes | aclitaxel- |
| T13 | 481-491 | C0144576 | denotes | aclitaxel |
| T14 | 69-75 | C0521447 | denotes | uclear |
| T15 | 1322-1331 | C0205263 | denotes | nduction |
| T16 | 635-642 | C0205263 | denotes | nduced |
| T17 | 177-184 | C0205263 | denotes | nduced |
| T18 | 118-125 | C0205263 | denotes | nduced |
| T19 | 1649-1659 | C1879547 | denotes | ctivation, |
| T20 | 87-96 | C1879547 | denotes | ctivated |
| T21 | 1661-1664 | C1515370 | denotes | asL |
| T22 | 1485-1489 | C1515370 | denotes | asL |
| T23 | 1335-1339 | C1515370 | denotes | asL. |
| T24 | 769-773 | C1515370 | denotes | asL |
| T25 | 610-614 | C1515370 | denotes | asL |
| T26 | 126-136 | C1515370 | denotes | as ligand |
| T27 | 7-15 | C0127400 | denotes | ediated |
| T28 | 1682-1691 | C0162638 | denotes | poptosis |
| T29 | 1385-1394 | C0162638 | denotes | poptosis |
| T30 | 804-813 | C0162638 | denotes | poptosis. |
| T31 | 643-652 | C0162638 | denotes | poptosis. |
| T32 | 167-176 | C0162638 | denotes | poptosis |
| T33 | 1261-1272 | C0026046 | denotes | icrotubule |
| T34 | 981-992 | C0026046 | denotes | icrotubule |
| T35 | 1714-1729 | C0031715 | denotes | hosphorylation. |
| T36 | 1568-1582 | C0031715 | denotes | hosphorylation |
| T37 | 1282-1286 | C0162388 | denotes | ill |
| T38 | 542-545 | C0162388 | denotes | ill |
| T39 | 1120-1127 | C0007610 | denotes | ucleus. |
| T40 | 404-407 | C0219474 | denotes | ax |
| T41 | 243-258 | C0017710 | denotes | lucocorticoids. |
| T42 | 615-622 | C0018790 | denotes | nhibits |
| T43 | 158-166 | C0018790 | denotes | nhibits |
| T44 | 598-606 | C0021027 | denotes | ntibody |
| T45 | 1506-1513 | C1280500 | denotes | ffects |
| T46 | 837-843 | C1280500 | denotes | ffect |
| T47 | 461-467 | C1280500 | denotes | ffects |
| T48 | 321-328 | C1280500 | denotes | ffects |
| T49 | 1044-1051 | C0006675 | denotes | alcium- |
| T50 | 1398-1408 | C3463820 | denotes | nhibiting |
| T51 | 339-349 | C0376525 | denotes | imerizing |
| T52 | 947-967 | C0040648 | denotes | ranscription factor |
| T53 | 1447-1468 | C1518440 | denotes | uclear translocation, |
| T54 | 1142-1163 | C1518440 | denotes | uclear translocation, |
| T55 | 871-892 | C1518440 | denotes | uclear translocation |
| T56 | 1666-1676 | C0185117 | denotes | xpression, |
| T57 | 1490-1500 | C0185117 | denotes | xpression. |
| T58 | 755-765 | C0185117 | denotes | xpression |
| T59 | 1622-1626 | C1167622 | denotes | ind |
| T60 | 1004-1011 | C1167622 | denotes | inding |
| T61 | 1242-1247 | C0013227 | denotes | rugs |
| T62 | 502-507 | C0013227 | denotes | rugs |
| T63 | 389-395 | C0015576 | denotes | amily |
| T64 | 1627-1638 | C1149946 | denotes | alcineurin, |
| T65 | 1029-1040 | C1149946 | denotes | alcineurin, |
| T66 | 819-828 | C0441712 | denotes | echanism |
| T67 | 430-439 | C0441712 | denotes | echanism |
| T68 | 1052-1061 | C0851827 | denotes | ependent |
| T69 | 580-589 | C0851827 | denotes | ependent |
| T70 | 447-460 | C2986514 | denotes | ntiapoptotic |
| T71 | 307-320 | C2986514 | denotes | ntiapoptotic |
| T72 | 276-284 | C1272684 | denotes | ccepted |
| T73 | 1208-1215 | C0700364 | denotes | ppears |
| T74 | 412-415 | C0205169 | denotes | ad. |
| T75 | 778-783 | C2828370 | denotes | locks |
| T76 | 1433-1441 | C0332206 | denotes | locking |
| T77 | 296-302 | C0015264 | denotes | xerts |
| T78 | 1169-1178 | C1706006 | denotes | asL gene |
| T79 | 210-219 | C0332257 | denotes | ncluding |
| T80 | 1182-1184 | C1518422 | denotes | ot |
| T81 | 1530-1538 | C2983310 | denotes | vercome, |
| T82 | 1305-1309 | C0449719 | denotes | art |
| T83 | 662-667 | C0150312 | denotes | ound |
| T84 | 858-865 | C1292733 | denotes | revents |
| T85 | 521-541 | C1156019 | denotes | icrotubule dynamics |
| T86 | 368-375 | C0680022 | denotes | embers |
| T87 | 679-693 | C1514559 | denotes | verexpression |
| T88 | 1543-1548 | C0547044 | denotes | east |
| T89 | 1062-1073 | C1149880 | denotes | hosphatase |
| T90 | 1282-1292 | C0599733 | denotes | ill cells |
| T91 | 1372-1384 | C0458082 | denotes | rug-induced |
| T92 | 1108-1112 | C0560560 | denotes | ove |
| T93 | 993-999 | C0010957 | denotes | amage) |
| T94 | 1696-1701 | C2745955 | denotes | ccur |
| T95 | 190-197 | C2346866 | denotes | ariety |
| T96 | 721-733 | C0392920 | denotes | hemotherapy |
| T97 | 694-699 | C0181586 | denotes | eads |
| T98 | 201-208 | C0234402 | denotes | timuli, |
| T99 | 707-717 | C2700409 | denotes | revention |
| T100 | 547-552 | C0007634 | denotes | ells |
| T101 | 1016-1027 | C1753316 | denotes | equestering |
| T102 | 1474-1484 | C0309872 | denotes | reventing |
| T103 | 1273-1281 | C0542341 | denotes | unction |
| T104 | 910-916 | C1521761 | denotes | actor |